2022 International Congress Archives - Page 123 of 153

Safety and Efficacy of Verdiperstat, a Novel Myeloperoxidase Inhibitor, in MSA

I. Qureshi, V. Wirtz, L. Brady, J. Ellison, A. Ellenbogen, R. Freeman, G. Höglinger, H. Kaufmann, A. Lang, P. Low, W. Meissner, P. Millar Vernetti, H. Morris, J. Palma, S. Perlman, W. Poewe, J. Schmahmann, K. Seppi, W. Singer, S. Vernino, G. Wenning (New Haven, USA)
Safety and Tolerability of Apomorphine Sublingual Film and Subcutaneous Apomorphine for the Treatment of OFF Episodes in Parkinson’s Disease

O. Rascol, W. Poewe, F. Stocchi, R. Chaudhuri, J. Kassubek, L. Lopez Manzanares, V. Leta, I. Zhang, A. Bowling, S. Wu, E. Pappert (Toulouse, France)
Safety and tolerability of Nilotinib in patients with Huntington’s disease

K. Anderson (Washington, USA)
Safety of incobotulinumtoxinA in pediatrics: A pooled analysis

F. Heinen, M. Banach, E. Dabrowski, D. Gaebler-Spira, H. Chambers, S. Schroeder, T. Geister, M. Althaus, A. Hanschmann, S. Berweck (Munich, Germany)
Safety of opicapone after 5 years of post-marketing experience worldwide

L. Guedes, J. Graça, M. Sampaio, M. Vieira, F. Rocha, H. Gama (Coronado, Portugal)
Safety, Target Engagement and Effects of Bosutinib in Dementia with Lewy Bodies

F. Pagan, Y. Torres-Yaghi, M. Hebron, R. Turner, B. Wilmarth, S. Matar, D. Ferrante, J. Ahn, C. Moussa (Washington, USA)
Safinamide adherence: the experience of the movement disorder unit of Trieste.

M. Catalan, M. Liccari, V. Tommasini, L. Antonutti, P. Manganotti (Trieste, Italy)
Safinamide as an adjunct to Levodopa Therapy in Asian and Caucasian Patients with Parkinson’s Disease and Motor Fluctuations: A post-hoc Analysis of the SETTLE study

R. Bhidayasiri, T. Ishida, RE. Husni, T. Kamei, I. Suzuki, SL. Wu, JW. Cho (Bangkok, Thailand)
SAFINAMIDE: REAL LIFE STUDY. EFFICACY IN SWITCH FROM RASAGILINA AND LOW-DOSE TREATMENT.

MI. Morales-Casado, N. López-Ariztegui, DD. García-Meléndez, A. Diezma-Martín (Toledo, Spain)
Sarcopenia Screening with Limb Circumference and Impacts of Sarcopenia in Parkinson’s disease

SJ. Kim, YJ. Jeong, SM. Cheon ()